Health Technology Assessment (Oct 2009)

Lapatinib for the treatment of HER2-overexpressing breast cancer

  • J Jones,
  • A Takeda,
  • J Picot,
  • C von Keyserlingk,
  • A Clegg

DOI
https://doi.org/10.3310/hta13suppl3/01
Journal volume & issue
Vol. 13, no. Suppl 3

Abstract

Read online

No abstracts available.